Ho Carole - Insider Non-Derivative Transactions at Denali Therapeutics Inc. (DNLI) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 21, 2024, Ho Carole's relationship to Denali Therapeutics Inc. (DNLI) is Officer (Chief Medical Officer), and currently has 124,717 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other DNLI insiders.

Data Source: SEC.
Ho Carole - Insider Non-Derivative Transactions of DNLI Common Stock
Ho Carole - Insider Non-Derivative Transactions at DNLI
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 22, 2024 Sell -- (Common Stock) 5907 24.96 118810
Aug 22, 2024 Sell -- (Common Stock) 14098 24.41 124717
Aug 21, 2024 Sell -- (Common Stock) 2453 23.79 138815
Aug 14, 2024 Sell -- (Common Stock) 2337 22.89 141268
Feb 15, 2024 Sell -- (Common Stock) 1405 17.79 143605
Feb 14, 2024 Sell -- (Common Stock) 2784 17.29 145010
Jan 11, 2024 Sell -- (Common Stock) 4668 19.02 147794
Jan 6, 2024 Sell -- (Common Stock) 9972 19.43 198777
Jan 4, 2024 Acquisition -- (Common Stock) 53720 0 162434
Aug 24, 2023 Sell -- (Common Stock) 2522 23.22 182809
Aug 22, 2023 Sell -- (Common Stock) 2478 22.6 185331
Aug 15, 2023 Sell -- (Common Stock) 2768 23.79 182809
Aug 11, 2023 Sell -- (Common Stock) 2857 24.15 185577
Feb 16, 2023 Sell -- (Common Stock) 1476 29.4 182809
Feb 14, 2023 Sell -- (Common Stock) 2548 30.1 184285
Feb 11, 2023 Sell -- (Common Stock) 818 29.8 179365
Feb 9, 2023 Sell -- (Common Stock) 1521 30.88 180183
Jan 10, 2023 Sell -- (Common Stock) 1459 28.48 177454
Jan 7, 2023 Sell -- (Common Stock) 1451 28.67 178913
Jan 6, 2023 Sell -- (Common Stock) 2636 28.44 180364
Jan 5, 2023 Sell -- (Common Stock) 2913 28.69 175500
Jan 4, 2023 Acquisition -- (Common Stock) 41120 0 138967